David Tuller has been conducting a series of interviews on YouTube relating to science, medicine, and medical controversies relating to ME/CFS and Long Covid. I was pleased to discuss with him my recently published book and, for good measure, the issue of dualism as it affects the psychologising of illness. […]
Long COVID
ME, Long Covid, and the History of Medical Stigma (Transcript)
Here is a transcript of my recent podcast with the Norwegian ME Association. In the interview, we discuss the medical stigma where post-viral illnesses, such as ME and Long COVID, are falsely characterised as ‘psychological’ due to poorly grounded stereotyping. The discussion touches on how medical opinion has become intertwined […]
ME, Long Covid, and the History of Medical Stigma (Podcast)
I recently had the pleasure of talking with the folks at the Norwegian ME Association for their (excellently produced) podcast series. Arising from my new book, we discussed the medical stigma in which an illness is falsely characterised as ‘psychological’ — post-viral conditions such as ME and Long Covid, for […]
Medical haste, COVID-19, and the mythology of “Medically Unexplained Symptoms”
Here is an extract from a lecture I gave last year for my colleagues at the Psychiatric Association of Turkey. It concerns the issue of so-called “Medically Unexplained Symptoms”: I attempt to show how the primacy effect — a reliance on first impressions — serves to distort medical reasoning. For […]
No, that antibody study does *not* show that Long COVID is caused by “beliefs”
The pandemic of Long COVID psychobabble continues. This week saw yet another terrible study claiming that long-haul COVID is just an illusion of human cognition, an illness-like experience rooted in psychological processes. The widely reported “finding” was published in the medical journal JAMA Internal Medicine by a group of French […]
The new NICE Guideline for ME/CFS: Ten Questions Answered
[UPDATED: 29 October 2021] 1. What’s going on? 2. How is the new guideline different to the old one? 3. Why is the new guideline being welcomed? 4. Why was the old guideline problematic? 5. How did NICE arrive at the new guideline? 6. Was NICE overly harsh in using […]